Steroid regulation of tryptophan hydroxylase protein in the dorsal raphe of macaques

Biological Psychiatry

Volumn 47, Issue 6, 1999, Pages 562-576

  Bethea, Cynthia L ^a   Mirkes, Stephanie J ^a   Shively, Carol A ^b   Adams, Michael R ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Depression; Dorsal raphe; Estrogen; Macaque; Medroxyprogesterone acetate; Progesterone; Serotonin; Tryptophan hydroxylase

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; ESTROGEN; MEDROXYPROGESTERONE ACETATE; PROGESTERONE; SEROTONIN; TAMOXIFEN CITRATE; TRYPTOPHAN HYDROXYLASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DEPRESSION; DORSAL RAPHE NUCLEUS; ENZYME ACTIVITY; FEMALE; IMMUNOCYTOCHEMISTRY; IMPLANT; MACACA; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; SEROTONINERGIC SYSTEM;

ANIMALS; BLOTTING, WESTERN; CARRIER PROTEINS; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; HORMONE REPLACEMENT THERAPY; IMMUNOHISTOCHEMISTRY; MACACA; OVARIECTOMY; PROGESTINS; RAPHE NUCLEI; RNA, MESSENGER; SEROTONIN; TAMOXIFEN; TRYPTOPHAN HYDROXYLASE;

EID: 0342980416     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(99)00156-0     Document Type: Article

References (67)

1. Adams M.R., Kaplan J.R., Manuck S.B., et al. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys lack of an effect of added progesterone . Arteriosclerosis. 10:1990;1051-1057.
2. Adams M.R., Register T.C., Golden D.L., Wagner J.D., Williams J.K. Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler Thromb Vasc Biol. 17:1997;217-221.
3. Alves S.E., Weiland N.G., Hastings N.B., Tanapat P., McEwen B.S. Estradiol regulation of 5HT neurons in the dorsal raphe of the rat differs from the monkey an analysis of tryptophan hydroxylase mRNA levels . Soc Neurosci. 23:1997;1222.
4. Alves S.E., Weiland N.G., Hayashi S., McEwen B.S. Immunocytochemical localization of nuclear estrogen receptors and progestin receptors within the rat dorsal raphe nucleus. J Comp Neurol. 391:1998;322-334.
5. Bimonte H.A., Denenberg V.H. Estradiol facilitates performance as working memory load increases. Psychoneuroendocrinology. 24:1999;161-173.
6. Blakely R.D., Ramamoorthy S., Schroeter S., et al. Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins. Biol Psychiatry. 44:1998;169-178.
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72:1976;248-254.
8. Cathcart C.K., Jones S.E., Pumroy C.S., Peters G.N., Knox S.M., Cheek J.H. Clinical recognition and management of depression in node negative breast cancer patients treated with tamoxifen. Breast Cancer Res Treat. 27:1993;277-281.
9. Clarkson T.B., Cline J.M., Williams J.K., Anthony M.S. Gonadal hormone substitutes effects on the cardiovascular system . Osteoporosis Int. 1:(suppl 7):1997;43-51.
10. Clarkson T.B., Shively C.A., Morgan T.M., Koritnik D.R., Adams M.R., Kaplan J.R. Oral contraceptives and coronary artery atherosclerosis of cynomolgus monkeys. Obstet Gynecol. 75:1990;217-222.
11. Cleare A.J., Murray R.A., O'Keane V. Reduced prolactin and cortisol responses to d-fenfluramine in depressed compared to healthy matched control subjects. Neuropsychopharmacology. 14:1996;349-354.
12. Costantino J.P., Kuller L.H., Ives D.G., Fisher B., Dignam J. Coronary heart disease mortality and adjuvant tamoxifen therapy. J Natl Cancer Inst. 89:1997;776-782.
13. de Lignieres B., Vincens M. Differential effects of exogenous oestradiol and progesterone on mood in post-menopausal women individual dose/effect relationship . Maturitas. 4:1982;67-72.
14. Dumas S., Darmon M.C., Delort J., Mallet J. Differential control of tryptophan hydroxylase expression in raphe and in pineal gland Evidence for a role of translation efficiency . J Neurosci. 24:1989;537-547.
15. Eriksson E., Hedberg M.A., Andersch B., Sundblad C. The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology. 12:1995;167-176.
16. Fink G., Sumner B.E.J., Rosie R., Grace O., Quinn J.P. Estrogen control of central neurotransmission effect on mood, mental state, and memory . Cell Mol Neurobiol. 16:1996;325-344.
17. Gitlin M.J., Pasnau R.O. Psychiatric syndromes linked to reproductive function in women a review of current knowledge . Am J Psychiatry. 146:1989;1413-1422.
18. Gregoire A.J.P., Kumar R., Everitt B., Henderson A.F., Studd J.W.W. Transdermal oestrogen for treatment of severe postnatal depression. Lancet. 347:1996;930-933.
19. Grodstein F., Stampfer M.J., Colditz G.A., et al. Postmenopausal hormone therapy and mortality. N Engl J Med. 336:1997;1769-1775.
20. Halbreich U. Role of estrogen in postmenopausal depression. Neurology. 48:(Sup7):1997;S16-S20.
21. Halbreich U, Piletz J, Halaris A (1992): Influence of gonadal hormones on neurotransmitters, receptor, cognition and mood. Clin Neuropharmacol15(suppl 1) Pt. A:590A-591A.
22. Halbreich U., Rojansky N., Palter S., Tworek H., Hissin P., Wang K. Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry. 37:1995;434-441.
23. Halbreich U., Tworek H. Altered serotonergic activity in women with dysphoric premenstrual syndromes. Int J Psychiatry Med. 23:1993;1-27.
24. Halbreich U., Vital-Herne J., Goldstein S., Zander K. Sex-related differences in depression A reappraisal Can gender differences in prevalence of depression be attributed to biological differences? Psychopharmacol Bull. 20:1984;472-474.
25. Horwitz K.B. Editorial:When tamoxifen turns bad. Endocrinology. 136:1995;821-823.
26. Hulley S., Grady D.D., Bush T., et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 280:1998;605-613.
27. Johansen P.A., Jennings I., Cotton R.G., Kuhn D.M. Phosphorylation and activation of tryptophan hydroxylase by exogenous protein kinase A. J Neurochem. 66:1996;817-823.
28. Klink R., Debonnel G. Functional modulation of rat dorsal raphe serotonergic neruons by ovarian steroids. Soc Neurosci. 24:1998;1757.
29. Kuhn D.M., Arthur R. Jr, States J.C. Phosphorylation and activation of brain tryptophan hydroxylase Identification of serine-58 as a substrate site for protein kinase A . J Neurochem. 68:1997;2220-2223.
30. Kumer S.C., Mockus S.M., Rucker P.J., Vrana K.E. Amino-terminal analysis of tryptophan hydroxylase protein kinase phosphorylation occurs at serine-58 . J Neurochem. 69:1997;1738-1745.
31. Love R.R., Mazess R.B., Barden H.S., et al. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N Engl J Med. 326:1992;852-856.
32. MacKenzie T.B. Lifetime prevalence of psychiatric disorders in women with perimenstrual difficulties. J Affect Disord. 10:1986;15-19.
33. Marcus R. Use of estrogen for prevention and treatment of osteoporosis. Endocrine. 6:1997;207-211.
34. Mitchell P., Smythe G. Hormonal responses to fenfluramine in depressed and control subjects. J Affective Disord. 19:1990;43-51.
35. Miyagawa K., Rosch J., Stanczyk F., Hermsmeyer K. Medroxyprogesterone interferes with ovarian steroid protection against coronary vasospasm. Nature Med. 3:1997;324-327.
36. Mortola J.F. A risk-benefit appraisal of drugs used in the management of premenstrual syndrome. Drug Safety. 10:1994;160-169.
37. Murphy D.D., Segal M. Regulation of dendritic spine density in cultured hippocampal neurons by steroid hormones. J Neurosci. 16:1996;4059-4068.
38. O'Keane V., Dinan T.G. Prolactin and cortisol responses to d-fenfluramine in major depression evidence for diminished responsivity of central serotonergic function . Am J Psychiatry. 148:1991;1009-1015.
39. Oppenheim G. Estrogen in the treatment of depression neuropharmacological mechanisms . Biol Psychiatry. 18:1983;721-725.
40. Owens M.J., Nemeroff C.B. Role of serotonin in the pathophysiology of depression focus on the serotonin transporter . Clin Chem. 40:1994;288-295.
41. Pearlstein T.B. Hormones and depression what are the facts about premenstrual syndrome, menopause and hormone replacement therapy? Am J Obstet Gynecol. 173:1995;646-653.
42. Pecins-Thompson M., Bethea C.L. Ovarian steroid regulation of 5HT1A autoreceptor messenger ribonucleic acid expression in the dorsal raphe of rhesus macaques. Neuroscience. 89:1998;267-277.
43. Pecins-Thompson M., Brown N.A., Bethea C.L. Regulation of serotonin re-uptake transporter mRNA expression by ovarian steroids in rhesus macaques. Mol Brain Res. 53:1998;120-129.
44. Pecins-Thompson M., Brown N.A., Kohama S.G., Bethea C.L. Ovarian steroid regulation of tryptophan hydroxylase mRNA expression in rhesus macaques. J Neurosci. 16:1996;7021-7029.
45. Resko J.A., Norman R.L., Niswender G.D., Spies H.G. The relationship between progestins and gonadotropins during the late luteal phase of the menstrual cycle in rhesus monkeys. Endocrinology. 94:1974;128-135.
46. Resko J.A., Ploem J.G., Stadelman H.L. Estrogens in fetal and maternal plasma of the rhesus monkey. Endocrinology. 97:1975;425-430.
47. Schutzer W.A., Widmann A.A., Bethea C.L. Effect of estrogen (E) and progesterone (P) on CSF concentrations of biogenic amines in pigtail macaques. Soc for Neurosci. 23:1997;2039.
48. Schwartz S. Women and depression a Durkheimian perspective . Soc Sci Med. 32:1991;127-140.
49. Sherwin B.B. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab. 72:1991;336-343.
50. Sherwin BB (1996): Menopause, early aging and elderly women. In Jensvold MF, Halbreich U, Hamiltion JA editors. Psychopharmacology and Women: Sex, gender and hormones. Washington, DC: American Psychiatric Press, 225-240.
51. Sherwin B.B., Gelfand M.M. Sex steroids and affect in the surgical menopause a double-blind cross-over study . Psychoneuroendocrinology. 10:1985;325-335.
52. Sherwin B.B., Gelfand M.M. A prospective one-year study of estrogen and progestin in postmenopausal women effects on clinical symptoms and lipoprotein lipids . Obstet Gynecol. 73:1989;759-766.
53. Siever L.J., Murphy D.L., Slater S., de la Vega E., Lipper S. Plasma prolactin changes following fenfluramine in depressed patients compared to controls an evaluation of central serotonergic responsivity in depression . Life Sci. 34:1984;1029-1039.
54. Sommers D.K., Van Wyk M., Snyman J.R. Dexfenfluramine-induced prolactin release as an index of central synaptosomal 5-hydroxytryptamine during treatment with fluoxetine. Eur J Clin Pharmacol. 46:1994;441-444.
55. Sprangers S.A., West N.B., Brenner R.M., Bethea C.L. Regulation and localization of estrogen and progestin receptors in the pituitary of steroid treated monkeys. Endocrinology. 126:1990;1133-1142.
56. Steiner M., Steinber S., Stewart D., et al. Fluoxetine in the treatment of premenstrual dysphoria. N Engl J Med. 332:1995;1529-1534.
57. Stewart D.F., Boydell K.M. Psychologic distress during menopause associations across the reproductive life cycle . Int J Psychiatry Med. 23:1993;157-162.
58. Van de Kar L.D. Neuroendocrine aspects of the serotonergic hypothesis of depression. Neurosci Biobehav Rev. 13:1989;237-246.
59. Wagner J.D., Martino M.A., Jayo M.J., Anthony M.S., Clarkson T.B., Cefalu W.T. The effects of hormone replacement therapy on carbohydrate metabolism and cardiovascular risk factors in surgically postmenopausal cynomolgus monkeys. Metab: Clin Exp. 45:1996;1254-1262.
60. Webb P., Lopez G.N., Uht P.M., Kushner P.J. Tamoxifen activation of the estrogen receptor/Ap-1 pathway potential origin for the cell-specific estrogen-like effects of antiestrogens . Mol Endocrinol. 9:1995;443-456.
61. Weissman M.M., Klerman G.L. Gender and depression. Trends Neurosci. 8:1985;416-420.
62. Williams J.B.W., Spitzer R.L., Linzer M., et al. Gender differences in depression in primary care. Am J Obstet Gynecol. 173:1995;654-659.
63. Williams J.K., Honore E.K., Adams M.R. Contrasting effects of conjugated estrogens and tamoxifen on dilator responses of atherosclerotic epicardial coronary arteries in nonhuman primates. Circulation. 96:1997;1970-1975.
64. Williams J.K., Wagner J.D., Li Z., Golden D.L., Adams M.R. Tamoxifen inhibits arterial accumulation of LDL degradation products and progression of coronary artery artherosclerosis in monkeys. Arterioscl Thromb Vascular Biol. 17:1997;403-408.
65. Williams R.F., Gianfortoni J.G., Hodgen G.D. Hyperprolactinemia induced by an estrogen-progesterone synergy quantitative and temporal effects of estrogen priming in monkeys . J Clin Endocrinol Metab. 60:1985;126-132.
66. Yeoman-Kinney A., Vernon S.W., Frankowski R.F., Weber D.M., Bitsura J.M., Vogel V.G. Factors related to enrollment in the breast cancer prevention trial at a comprehensive cancer center during the first year of recruitment. Cancer. 76:1995;46-56.
67. Yonkers K.A., Chantilis S.J. Recognition of depression in obstetric/gynecology practices. J Amer Obstet Gynecol. 173:1995;632-638.